100 High Myopia Patient-reported Outcomes (PRO) and Performance Outcomes (PERFO)

NANot yet recruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

October 31, 2025

Primary Completion Date

November 30, 2025

Study Completion Date

November 30, 2028

Conditions
High Myopia
Interventions
OTHER

Quality of life questionnaire

The NEI-RQL-42 (National Eye Institute Refractive Quality of Life) questionnaire will be self-administered via a secure online platform to assess the impact of pathological myopia on quality of life.

OTHER

Performance Outcomes (PerfO)

"Three tests are planned to assess the impact of high myopia on critical aspects of mobility and safety, with the possibility of adjusting their scope based on pilot data.~* The first test involves an assessment of driving on a simulator, designed to evaluate the performance of detecting pedestrians in peripheral vision, with and without glare.~* The second test focuses on assessing mobility and obstacle avoidance under six levels of brightness.~* The third test evaluates visual search ability. It consists of finding spheres in everyday scenes in an apartment with six levels of contrast tested."

OTHER

Semi-structured interviews

Semi-structured interviews will only be offered to patients recruited in Phase 1 Qualitative and aim to further explore the information gathered from the NEI-RQL-42 questionnaire responses and the difficulties encountered during the performance tasks in the laboratory, by exploring in more detail the limitations encountered by patients with pathological myopia in their daily activities. These interviews will help identify the specific causes of the difficulties encountered, as well as the environmental conditions that may create discomfort or increased hardship.

All Listed Sponsors
lead

Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts

OTHER

NCT07101146 - 100 High Myopia Patient-reported Outcomes (PRO) and Performance Outcomes (PERFO) | Biotech Hunter | Biotech Hunter